chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 weeks pregnant; A bit of pain at injection site; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (5 weeks pregnant) and VACCINATION SITE PAIN (A bit of pain at injection site) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 05-Jan-2021 and the estimated date of delivery was 12-Oct-2021. On 06-Feb-2021, the patient experienced VACCINATION SITE PAIN (A bit of pain at injection site). On 11-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (5 weeks pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourth week of the pregnancy.  On 11-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (5 weeks pregnant) had resolved. At the time of the report, VACCINATION SITE PAIN (A bit of pain at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-1021, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Also reported patient doesn't know due date because they still have to study her pregnancy because maybe they are twins. No concomitant medications were provided No treatment information provided Gestational diabetes was observed with first baby  in August 2006 and gestational diabetes and born prematurely because they were twins. Born when 32 weeks.
she got numbness/numbness in her legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient received bnt162b2 (BNT162B2), on 02Apr2021 as dose 1, single (Lot number: ER8732) at the age of 54 years for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (non-serious), outcome "not recovered", described as "she got numbness/numbness in her legs". The event "she got numbness/numbness in her legs" required physician office visit and emergency room visit. Therapeutic measures were not taken as a result of hypoaesthesia. Additional information: Patient stated that she called about the Covid vaccination, a shot from Pfizer. She got three Pfizer vaccines. She had numbness in her legs sometimes. She clarified that she reported this previously. After the first vaccination she got numbness and it ran with the vaccinations. She was told that it was not from the vaccinations in the ER. She just kept going and she has got numbness in her legs. They emailed her all the time and asked how she was doing and they stopped doing it. She did a report on the phone previously. She later clarified that she reported this online with Pfizer previously. They were testing her for months and months and asked how she was feeling on a scale of 1-10 and then they stopped. She did not have anything medical she just went for the vaccination. She called because she went to a doctor because she was still having this numbness and was told that it was probably from the vaccinations because she has been having it since then. She went online and they sent something to ask how she was doing and how many days what was going on.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300353366 same patient/suspect drug, different dose number/event;
In addition to the symptoms listed on the info sheets, 48 hours after the vaccinations, pt is suffering with a bad runny nose, vomiting, loss of appetite, coughing and a sore throat.  He also cries and whimpers a lot.  He also has a fever and has had had jerky spasms at night.
4 minutes after given , developed 3cm redness and urticaria at site of injection. Given 2 ml Benadryl orally 20 minutes after redness down; no urticaria, no wheezing. No respiratory distress.
Vomiting, facial swelling and abdominal pain over a 12-18 hour period - received care in emergency department on 5/30/14 and had response to oral Decadron and Benadryl.
bicep is swelling; light red rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (bicep is swelling) and VACCINATION SITE RASH (light red rash) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 073L20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced VACCINATION SITE SWELLING (bicep is swelling) and VACCINATION SITE RASH (light red rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (bicep is swelling) and VACCINATION SITE RASH (light red rash) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. It was reported that the patient doesn't have any symptoms after his first dose.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow up received on 19-Jun-2021 and included significant information such as new reporter (HCP) was added, Contact details of Primary reporter was updated and details about patient first and second dose were added, Patient age was added and treatment information was added.
10days after shot, my arm got hot the spot got swollen. it was about 5 inches in diameter and it was hot red and swollen. Physically i had all the chronic fatigue attack where my mind is not sharp, I was depressed, and tired, and i was hurting. My hips were hurting, i have paraphasia in my right foot but it went from my toe to my knee and it was painful. lasted for 10days. I woke up Saturday and everything was fine and i was back happy. I am still stressed
Had a normal menstrual period from 4/27-5/4. Received second COVID vaccine on 4/30. Began a second, full menstrual period on 5/6-present.
Flu-like symptoms starting the night after the injection and continuing for about 24 hours. Achiness throughout the body, fever, tiredness, headache. Used ibuprofen during the 24 hours to treat the flu-like symptoms.  Also experiencing random sharp pains in various muscles, sometimes in the arms but mostly the legs. This has been ongoing, not every day but most days since the injection.
No adverse effects; a dose of PROQUAD was inadvertently administered to a 13 year old patient.; This spontaneous report has been received from a nurse referring to a 13-year-old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.     On 13-AUG-2019, the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot # S006832, expiration date reported as 02-SEP-2020; dose and route were not reported) for prophylaxis (inappropriate age at vaccine administration). No adverse effects was reported.
covid-19; Muscle pain/symptoms got worst; Joint pain; Soreness; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st December 2021, the patient received the 1st dose of Shingrix (intramuscular). In December 2021, between 2 and 3 weeks after receiving Shingrix, the patient experienced muscle pain, joint pain and pain. In January 2022, the patient experienced covid-19. On an unknown date, the outcome of the muscle pain, joint pain, pain and covid-19 were not recovered/not resolved.   It was unknown if the reporter considered the muscle pain, joint pain, pain and covid-19 to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient. The age at the vaccination was unknown. The reporter did not feel comfortable providing his date of birth, therefore, he stated that he was more 70 years-old. The patient had received Shingrix in left deltoid. The reporter did not have lot/expiry date and dose of Shingrix.  The reporter reported that after two and a half weeks later (after the vaccination), he experienced muscle pan, joint pain, soreness.  The reporter stated that during the first week of January 2022, he was diagnosed with covid-19 and the symptoms got worst. However, currently the symptoms were back how they initially were (before covid-19 was diagnosed). In other words, symptoms had not been resolved.  The reporter did not give a consent to follow-up with healthcare professional. Therefore, healthcare professional contact information was not collected.
Pt was given the Kinrix vaccination which is not approved for pt until the age of 4 which the nurse was unaware of
A physician reported that a 30 month old female received her first dose of Prevnar on 1/3/03, at 24 months of age. The child had no underlying medical conditions. On 6/20/03, the child developed unspecified symptoms of illness. On 6/25/03, the child was seen in an emergency room. A blood culture was taken, S. pneumoniae was isolated. That same day, the child was transferred to anothe hospital facility and admitted. Treatment medications included cefotaxime, clindamycin and gentamycin. On 6/26/03, the child was again transferred to another hospital facility and admitted to the ICU. A pleural fluid culture was taken, S. pneumoniae was isolated. Treatment medications included cefotaxime, clindamycin, and vancomycin for about a day. On 7/1/03, she had surgery for empyema decortication. As of 7/2/03, the child remained in the ICU and was receiving penicillin. The physician indicated that the S. pneumoniae isolates were sent for serotyping; serotype 3 was isolated. No further information was available at the date of this report.
Heart failure; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of CARDIAC FAILURE (Heart failure) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Aortic stenosis.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CARDIAC FAILURE (Heart failure) (seriousness criterion medically significant). At the time of the report, CARDIAC FAILURE (Heart failure) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, C-reactive protein: 12.1 (High) 12.1 (Normal Level, < 0.5). In June 2021, Ejection fraction: 60 percent (Inconclusive) 60 % in September and 30 percent (Inconclusive) Now 30%.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.  Very limited information regarding this event has been provided at this time. Further information has been requested. Of note, the patient's medical history of Aortic Stenosis is a confounding factor that may play a possible contributory role.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested. Of note, the patient's medical history of Aortic Stenosis is a confounding factor that may play a possible contributory role.
25jul90 pt vax hepta B. pt devel extreme fatigue and malaise for 1 month. 05sep90 pt vax 2nd hepta B.  fatigue persisted.
Moderna COVID-19 Vaccine  Woke up in the morning (about 15 hours post vac) with weakness on my left side (the vaccine was given in my left arm).  I was unable t put weight on my left leg for a few minutes.
ACUTE PULMONARY EMBOLISM 10/21/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. Patient's medical history and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with improperly stored doses of PEDVAXHIB (dose, frequency, indication and route of administration were not reported, lot # reported as M014926 with expiration date: 17-FEB-2019). Concomitant medications were not reported. No adverse events were reported. It was not specified if the data digital logger was involved, (temperature excursion: 51.24F, time frame: 40 minutes). This is one of several reports received from the same reporter. Additional information has been requested.
Evening of 12-16-09 - area around injection site was slightly red and swollen - area continued to increase in redness and area became more swollen and hot to the touch - 12-18-09 area around inj. site measured 5"X4 3/4", was extremely red, swollen and hot to the touch - Physician was contacted by patient's mother.
Left upper extremity deep venous thrombosis of L jugular and L subclavian. Symptoms of L arm swelling started 10/24/23 and blood clot was diagnosed by ultrasound on 11/1/23
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age. On 25-MAR-2014, the patient was vaccinated with PROQUAD (Merck), 0.5 ml, subcutaneous (lot number H045787, expiry date 24-FEB-2014). On 25-MAR-2014, the patient received an expired dose of PROQUAD. The outcome of patient received an expired dose of PROQUAD was unknown. Additional information has been requested.
2 days after administration of DTaP and MMR to left deltoid, her entire left upper arm from shoulder to elbow became red and swollen with a 5cm round area of large vesicles up to 1cm in size on left upper arm. Bacterial culture of vesicles was negative. Antibiotics were prescribed.
Patient report itching and rash of the neck, upper arm and upper back  on Saturday 12/19/20 .  50 mg of Benadryl  taken on 12/19/20 and symptoms resolved on 12/19/20.
Acute Necrotizing Ulcerative Gingivitis (swelling, pain, ulceration involving lower teeth, gums, tongue and lips)
Severe pain, swelling, redness and fever at location, joint pain, fever from time of injection. Joint pain is better now, fever is gone, but location is still extremely painful, swollen, and hot to touch.
This spontaneous report as received from physician assistant refers to unspecified number of patients of unknown age and gender. Patients concurrent conditions and relevant history was not reported. The reporter stated that improperly stored doses of PEDVAX HIB (lot number, dose and route unspecified) was administered to unspecified number of patients on unknown dates. Concomitant medications were unknown. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with PEDVAX HIB was not reported. Product quality issue was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient developed a morbilliform blanchable rash on cheeks of face trunk and extremities after receiving the MMR vaccine.
A non-serious spontaneous report of inadvertent administration of expired H1N1 LAIV was received from a registered nurse/health professional concerning a seven-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The original expiration date was 08-Apr-2010, which was reassigned to 29-Mar-2010. On 31-Mar-2010, the patient received the second dose of H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable and the event was considered to be resolved.
Initially left arm became extremely painful at injection site. Then within an hour it was bright red raised round in-duration approximately 4 in across. Swelling increased with the evening over the injection site, raising the deltoid area. Extreme itching began in the left axilla. Pain radiated down the left arm into the thumb. Pain radiated up the left side of the neck making it difficult to turn or move head without pain.  Headache began by evening aggravated by neck pain. By night I ached all over and joints especially. By the next morning a butterfly rash appeared across my face and then began to peel like a sunburn. By the evening of the next day my arms were flushed, dry, rashy but no peeling.  I dealt with the pain with Tylenol and Advil.  This shot is mandatory for hospital work.  I would not ever want this again. Give me the flu instead.
Received Gardasil and Hepatitis A.  Hour after getting right arm tremors, couldn't stand up.  States lasted all day.  Head felt empty, felt weird.  Next day better but still dizzy and hand shaking.  Able to work, complaints of bumps on chest.  4-19-10 right arm still sore.  Complaints of face breaking out.  Thinks it's Gardasil.
Patient began to experience flu-like sx shortly after receiving the vaccine. She went to see her physician about 48 hrs after vaccine. Her arm was warm, painful, & swollen. She had a fever of 102. MD gave Rocephin IV Sunday, M, T, & Th. Oral Keflex 500 mg QID x 2 weeks.
Pt states after receiving vaccine, he developed a "half dollar size" lump.  On 13 Aug, after working out (fitness) member experienced HA, nausea, rash at immunization site.  Rash is currently 20 cm x 10 cm in size on left arm, visible redness and warmth to touch.
Severe headache, severe abdominal pain, nausea, tiredness, lack of energy, generalized body aches (2.5 days) vomiting (1 episode the morning after injection was received) lack of appetite (1 day) chills (0.5 day) left arm pain, redness, swelling, and warmth  (3 days and persists but has improved) Mild headache and body aches persist  Symptoms treated with self care at home and OTC medications - Naproxen, Headache/Migraine Relief, Acetaminophen  Symptoms have improved significantly but some persist as stated above
VACCINE WAS GIVEN OUT OF THE TEMPERATURE RANGE TO THE PATIENT.  NO SIGNS OR SYMPTOMS WERE REPORTED OR OBSERVED
Patient did not report any adverse issues with vaccine. She is under the recommended age to get the vaccine. she is under 60 years old.
1) Swelling/redness locally at site of shot lasting about 2 weeks. 2) 4 Pustular/vesicular lesions near site of injection occurring approximately 10 days after shot and fading approximately 4 days later.
receiving the Covid vaccine I started my cycle; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 14:00 (Lot number: ER8730) at the age of 52 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "I am perimenopausal and have an IUD" (ongoing); "Psoriatic arthritis" (unspecified if ongoing); "IUD" (unspecified if ongoing), notes: IUD. Concomitant medication(s) included: VITAMIN D NOS; NEXIUM [ESOMEPRAZOLE SODIUM]; IBUPROFEN; IRON. The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 15Apr2021, outcome "unknown", described as "receiving the Covid vaccine I started my cycle". Therapeutic measures were not taken as a result of menstrual disorder.  Additional information: Facility type vaccine was other. No other vaccine in four weeks. She was perimenopausal and had an IUD. She had not a menstrual cycle (other than occasional very light spotting) in 5+ years. 17 days after receiving the COVID vaccine she started her cycle. It had lasted 5 days already and had soaked approximately 2 pads per day. No known allergies.  No follow-up attempts are possible. No further information is expected.
12/24/20 Dose #1 received. Next day developed "restless legs" in bilateral legs, at least 5-8 episodes per day, no improvement.  1/22/21 Dose #2 received. Developed severe headache, takes Ibuprofen and Tylenol, now improved but still did not resolve.
My moth began to tingle. The feeling moved into my lips, chin, nose.   My breathing was not impacted.  I went home and took 1 Benadryl at 3:00. I took another Benadryl at 8:00 and it started to get better.  I woke up at 3:00am  and it was gone.
PT HAS HISTORY OF FAINTING AFTER RECEIVING VACCINES. HE WAS ADVISED TO WAIT FOR 30 MINUTES PRIOR TO LEAVING AFTER RECEIVING THE SHOT. ABOUT 5 MINUTES AFTER ADMINISTRATION, THE PATIENT LOST CONSCIOUSNESS. HE WAS LAID DOWN, ICE PACKS ON NECK AND HEAD AND ADVISED TO WAIT. HE RECOVERED AND HAD NO OTHER ISSUES.
I am immediately feeling nauseous and my symptoms are already beginning to mimic the height of my Covid symptoms. I had Covid twice which was not bad either time, and the vaccine is already becoming noticeably worse. I want to make sure I?m tracking as well as possible all negative side effects because I was not able to work without getting the vaccine and I am horribly concerned already because I?ve never got a shot that made me feel this bad.
Purpuric rash with thrombocytopenia and wheezing. 10/13/06 Received medical records from hospital which reveal patient admitted 3/12-3/13/06 with final DX: acute bronchiolitis; thrombocytopenia; possible viral illness; & possible MMR reaction.  Patient had developed cough for 5 days prior to admit & rash for approx 1 week prior to admit.  Wheezing & occasional emesis with cough.  No fever.  Seen in PCP office 1 day prior to admit & noted to have petechiae & purpura on face & upper chest.  Labs at that time revealed mild thrombocytopenia.  No improvement by following AM & was admitted to hospital.  Admit exam revealed respiratory distress, nasal congestion, wheezing, costal retractions & generalized macular papular rash with petechiae & purpura on face & chest.  Responded to nebs & was d/c to home on nebs./ss
Hives/Rashes that look like elevated scratch marks appearing all over the body. Still currently happening even after the second shot. Have been asked to take an antihistamine at least once a day as well as benadryl and hydrocortisone if hives/rashes get aggravated. This started the day after the first vaccine shot and has continued since then. With the second Moderna shot, I also got the "Moderna arm" red elevation around the area of the shot which lasted 2-4 days.